{"as_of":"2026-08-19T16:06:00Z","caps":{"database_statements":6,"inbound":100,"outbound":100},"context_digest":"sha256:47af1d5e174f7d175ff910feeaf943829e70ab7c5f6c33f6620d362ad3c6f2d1","coverage":[{"denominator":38,"lane":"reference_resolution","note":"Typed states for the displayed outbound observations.","records_observed":38,"source":"paper_references, paper_reference_links","source_observed_at":"2026-08-15T23:38:45.918576Z","state":"measured"},{"denominator":38,"lane":"standing_notices","note":"One-hop event checks from named stored sources.","records_observed":38,"source":"scholarly_work_events, retraction_status_cache","source_observed_at":"2026-08-19T06:32:44.657259+00:00","state":"measured"},{"denominator":0,"lane":"inbound_itemization","note":"Pith citing papers itemized under the disclosed page cap.","records_observed":0,"source":"paper_references, paper_reference_links","source_observed_at":null,"state":"measured"},{"denominator":1,"lane":"external_citation_measurements","note":"A source-named dated measurement, never combined with another source.","records_observed":0,"source":"cited_works","source_observed_at":null,"state":"measured"}],"external_citation_measurements":[],"inbound":[],"links":{"evidence":"/evidence","html":"/paper/2505.04284/citation-record","integrity":"/paper/2505.04284/integrity","json":"/paper/2505.04284/citation-record.json","paper":"/paper/2505.04284"},"outbound":[{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-15T23:38:47.070839Z","title":null,"venue":null,"work_id":"03382ca7-b1be-4aab-83a4-bf0c811a20b7","year":2023},"citing_paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance","version":1},"reference_index":1,"source":"pdf_text","source_observed_at":"2026-08-15T23:38:44.980898Z"},"links":{"citing_paper":"/paper/2505.04284"},"observation_digest":"sha256:fd1888f89c35ac6f313965be040795bd8a5a2098d7c4a8dd8cc6abcb786167e7","observation_id":"2a1c14a7-3cdb-48ac-94ee-ea9a87d230eb","resolution":{"observed_at":"2026-08-15T23:38:47.076208Z","resolver_source":"raw_fallback","status":"unresolved"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-15T23:38:47.055106Z","title":"Abdin, J","venue":null,"work_id":"02b6d262-bcdd-4e10-ab84-575eb4461ba6","year":2024},"citing_paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance","version":1},"reference_index":2,"source":"pdf_text","source_observed_at":"2026-08-15T23:38:44.986525Z"},"links":{"citing_paper":"/paper/2505.04284"},"observation_digest":"sha256:b6105a5ccfe76f43596284f6384b1459b1d19162a764f7465989f23fd1a5ddd7","observation_id":"301f31cd-55dd-406a-b991-78d5756d81e0","resolution":{"observed_at":"2026-08-15T23:38:47.060344Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"2303.08774","last_updated":"2024-03-04T06:01:33Z","snapshot_observed_at":"2026-08-17T09:58:46.058102Z","submitted_at":"2023-03-15T17:15:04Z","title":"GPT-4 Technical Report","version":6},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2303.08774","snapshot_observed_at":"2026-08-15T23:38:44.991606Z","title":"Achiam, S","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance","version":1},"reference_index":3,"source":"pdf_text","source_observed_at":"2026-08-15T23:38:44.991606Z"},"links":{"cited_paper":"/paper/2303.08774","citing_paper":"/paper/2505.04284"},"observation_digest":"sha256:736f6c6ab7a5ee1a92dee159d783fd455cdb86042d2ca8017fed0ea1b8816cef","observation_id":"7218ec3a-2756-45cd-8fc2-3b1845a7aae9","resolution":{"observed_at":"2026-08-15T23:38:44.991606Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-15T23:38:44.996653Z","title":"Llama 3 model card","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance","version":1},"reference_index":4,"source":"pdf_text","source_observed_at":"2026-08-15T23:38:44.996653Z"},"links":{"citing_paper":"/paper/2505.04284"},"observation_digest":"sha256:8eedbdcc922a29b4fb7e03ed8a074d389f404dc397c9212f0cd06fa151998cff","observation_id":"63f65535-6ede-4336-ad93-d60933db00f2","resolution":{"observed_at":"2026-08-15T23:38:44.996653Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-15T23:38:45.001767Z","title":"Banerjee and A","venue":null,"work_id":null,"year":2005},"citing_paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance","version":1},"reference_index":5,"source":"pdf_text","source_observed_at":"2026-08-15T23:38:45.001767Z"},"links":{"citing_paper":"/paper/2505.04284"},"observation_digest":"sha256:2ea0b42e485091766375d7a3eae8b6f0017dda8cd0dbda38358bf5486c43b003","observation_id":"52e6e397-ad2d-4f1e-9c16-197409e0b9b4","resolution":{"observed_at":"2026-08-15T23:38:45.001767Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-15T23:38:46.989606Z","title":"when ‘bad’is ‘good’","venue":null,"work_id":"66c680d1-a2bd-4a33-9b8d-07915d9c6955","year":2016},"citing_paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance","version":1},"reference_index":6,"source":"pdf_text","source_observed_at":"2026-08-15T23:38:45.005934Z"},"links":{"citing_paper":"/paper/2505.04284"},"observation_digest":"sha256:a712abe1e370b914df2d2fc105e7e6cfed7b87d834ab9ced7a1dfbc80ffbbcc0","observation_id":"994e640b-1198-44ec-b6fb-e53b668e4c22","resolution":{"observed_at":"2026-08-15T23:38:47.023302Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-15T23:38:46.825791Z","title":"Dettmers, A","venue":null,"work_id":"493d1197-e028-46f8-85b8-8b99193cb36b","year":2024},"citing_paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance","version":1},"reference_index":7,"source":"pdf_text","source_observed_at":"2026-08-15T23:38:45.011568Z"},"links":{"citing_paper":"/paper/2505.04284"},"observation_digest":"sha256:53df12fb6e647433d24a89835f7a6f36be10556ea3ba882c66757acd78e4f627","observation_id":"8afe1a5c-b32c-4bd0-acd0-c4f9b6a3ef1f","resolution":{"observed_at":"2026-08-15T23:38:46.886217Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-15T23:38:46.810172Z","title":"for Disease Control, Prevention, et al","venue":null,"work_id":"d8e9ed0a-9772-439d-a476-c514ecaecdb5","year":2022},"citing_paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance","version":1},"reference_index":8,"source":"pdf_text","source_observed_at":"2026-08-15T23:38:45.015769Z"},"links":{"citing_paper":"/paper/2505.04284"},"observation_digest":"sha256:64b85f1a493a54d12ef8e186cd1d3b8d54e6715db57ab728c16dfcf53a0a00a9","observation_id":"03548d98-ce7a-4cfe-a83f-4b828419adee","resolution":{"observed_at":"2026-08-15T23:38:46.815058Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-15T23:38:46.794624Z","title":"Ghosh, A","venue":null,"work_id":"b27c0102-4240-4502-8542-22639b3b305d","year":2024},"citing_paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance","version":1},"reference_index":9,"source":"pdf_text","source_observed_at":"2026-08-15T23:38:45.020388Z"},"links":{"citing_paper":"/paper/2505.04284"},"observation_digest":"sha256:2a65909883d40ef009330c83c23443de1d06dccef3ebb040b016d60576bb445b","observation_id":"351f95fc-5709-4ae3-b12b-d9d21ff58a0f","resolution":{"observed_at":"2026-08-15T23:38:46.800006Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-15T23:38:46.777260Z","title":"Ghosh, A","venue":null,"work_id":"c065c003-4f9a-47cb-8f41-05131f4c5ea1","year":null},"citing_paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance","version":1},"reference_index":10,"source":"pdf_text","source_observed_at":"2026-08-15T23:38:45.090228Z"},"links":{"citing_paper":"/paper/2505.04284"},"observation_digest":"sha256:3e7863403d141fd4a5c45d9f31dbb26ee06644cb6165993df3230cace450519a","observation_id":"5c748783-c043-40b0-bbbe-c7482b724955","resolution":{"observed_at":"2026-08-15T23:38:46.783334Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-15T23:38:46.683654Z","title":"Ghosh, M","venue":null,"work_id":"add0720b-8c2c-4a5d-8637-7e4c5db114e5","year":2024},"citing_paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance","version":1},"reference_index":11,"source":"pdf_text","source_observed_at":"2026-08-15T23:38:45.182162Z"},"links":{"citing_paper":"/paper/2505.04284"},"observation_digest":"sha256:5ccd966c1cbdb8221090e92744534075c01deb41e5f4e8c48a04e95a19c36505","observation_id":"6402a678-4251-4e87-9275-ecedc97d74cb","resolution":{"observed_at":"2026-08-15T23:38:46.766696Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-15T23:38:46.602935Z","title":"Gurulingappa, A","venue":null,"work_id":"bd515d76-b150-4076-a232-93eeeda2b167","year":2012},"citing_paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance","version":1},"reference_index":12,"source":"pdf_text","source_observed_at":"2026-08-15T23:38:45.295048Z"},"links":{"citing_paper":"/paper/2505.04284"},"observation_digest":"sha256:45a988f7d0f91ed4317b5eb53f93d1d115bfe12444a5e780d15dba793d14f0b2","observation_id":"2259b264-985a-43ca-b443-06a6cb35fcec","resolution":{"observed_at":"2026-08-15T23:38:46.608379Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"2304.08247","last_updated":"2025-03-18T21:31:51Z","snapshot_observed_at":"2026-08-18T08:20:50.087566Z","submitted_at":"2023-04-14T11:28:08Z","title":"MedAlpaca -- An Open-Source Collection of Medical Conversational AI Models and Training Data","version":3},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2304.08247","snapshot_observed_at":"2026-08-15T23:38:45.300212Z","title":"Medalpaca–anopen-sourcecollectionofmedicalconversationalaimod- els and training data.arXiv preprint arXiv:2304.08247, 2023","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance","version":1},"reference_index":13,"source":"pdf_text","source_observed_at":"2026-08-15T23:38:45.300212Z"},"links":{"cited_paper":"/paper/2304.08247","citing_paper":"/paper/2505.04284"},"observation_digest":"sha256:99edd80628ffb0142eedee515c170735b18d9bd6a5909cd6d10d6fa1a453e144","observation_id":"5790ce2e-6732-454d-a8e8-9a86dd7d1fc7","resolution":{"observed_at":"2026-08-15T23:38:45.300212Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-15T23:38:46.588344Z","title":null,"venue":null,"work_id":"0c90b779-17c3-43c0-9cb1-0d209ac60366","year":2016},"citing_paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance","version":1},"reference_index":14,"source":"pdf_text","source_observed_at":"2026-08-15T23:38:45.305822Z"},"links":{"citing_paper":"/paper/2505.04284"},"observation_digest":"sha256:119fd621d0be570493d80ccdf3e9ee6504571477f3e1c12e0ce6c4a927d853f6","observation_id":"55402c90-aab5-4733-b27f-03a7aeb6b13d","resolution":{"observed_at":"2026-08-15T23:38:46.592975Z","resolver_source":"raw_fallback","status":"unresolved"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-15T23:38:46.574171Z","title":null,"venue":null,"work_id":"843b9346-2a1c-4f60-b650-11cf08d5ac1b","year":2021},"citing_paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance","version":1},"reference_index":15,"source":"pdf_text","source_observed_at":"2026-08-15T23:38:45.310697Z"},"links":{"citing_paper":"/paper/2505.04284"},"observation_digest":"sha256:ca0bf79e9919a8a1e7ea580839ac964c274f68621324fb100104028c977eb887","observation_id":"6e096438-f6c9-4fee-920f-be83ac40229e","resolution":{"observed_at":"2026-08-15T23:38:46.578776Z","resolver_source":"raw_fallback","status":"unresolved"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-15T23:38:46.559963Z","title":"Lavril, T","venue":null,"work_id":"f583a587-c2ba-4bc7-a81b-f90b207089ed","year":2023},"citing_paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance","version":1},"reference_index":16,"source":"pdf_text","source_observed_at":"2026-08-15T23:38:45.315299Z"},"links":{"citing_paper":"/paper/2505.04284"},"observation_digest":"sha256:a775437b273d2c0fa0dfff4602c91373384479213c8d9426739aacb2f5f188c7","observation_id":"b00874e7-96b7-4e32-a75a-37855491f21f","resolution":{"observed_at":"2026-08-15T23:38:46.564459Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-15T23:38:46.519879Z","title":"Joshi, D","venue":null,"work_id":"374bb928-d14c-4856-bf13-15eac64facdf","year":2020},"citing_paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance","version":1},"reference_index":17,"source":"pdf_text","source_observed_at":"2026-08-15T23:38:45.319989Z"},"links":{"citing_paper":"/paper/2505.04284"},"observation_digest":"sha256:e933f726552f6c99119c4b57726f19857f39890a82e695441035b3c8e645f629","observation_id":"cd6e8819-5b72-40f9-9b26-060bd3fa35b7","resolution":{"observed_at":"2026-08-15T23:38:46.548982Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-15T23:38:46.474636Z","title":"Karimi, C","venue":null,"work_id":"06fa92e2-f95d-4aa9-80f0-a0bc2655d5d4","year":2015},"citing_paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance","version":1},"reference_index":18,"source":"pdf_text","source_observed_at":"2026-08-15T23:38:45.324635Z"},"links":{"citing_paper":"/paper/2505.04284"},"observation_digest":"sha256:db740b2ee7828b990be149d3ee666f963ac4d939f0c37756a04926b5b2479cf3","observation_id":"2e5c2988-c7ec-42f7-8fe2-5c00e3adfb68","resolution":{"observed_at":"2026-08-15T23:38:46.480543Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-15T23:38:46.458083Z","title":null,"venue":null,"work_id":"bd519959-6acc-45f9-8128-23b7eac54bcb","year":2016},"citing_paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance","version":1},"reference_index":19,"source":"pdf_text","source_observed_at":"2026-08-15T23:38:45.329709Z"},"links":{"citing_paper":"/paper/2505.04284"},"observation_digest":"sha256:250ea17835defb34f43484775ac8de8835580f9b7aeab3d71de0a52b05caea08","observation_id":"393667c9-e471-4f52-af35-d59cc19f8a7a","resolution":{"observed_at":"2026-08-15T23:38:46.463598Z","resolver_source":"raw_fallback","status":"unresolved"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-15T23:38:46.442278Z","title":null,"venue":null,"work_id":"024ca1c2-e9e5-40be-a3ff-ccabdf5aec59","year":2020},"citing_paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance","version":1},"reference_index":20,"source":"pdf_text","source_observed_at":"2026-08-15T23:38:45.334550Z"},"links":{"citing_paper":"/paper/2505.04284"},"observation_digest":"sha256:e7b363149c027b7e42c7e9058cc7ba75eac346af3ebe5ec75405ade200876b1b","observation_id":"1ac1e7db-73f9-41e9-910c-94a1b9dfe40d","resolution":{"observed_at":"2026-08-15T23:38:46.447187Z","resolver_source":"raw_fallback","status":"unresolved"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-15T23:38:46.426921Z","title":null,"venue":null,"work_id":"500c46d8-23a3-4224-bf4f-5f6a32a0c2aa","year":2004},"citing_paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance","version":1},"reference_index":21,"source":"pdf_text","source_observed_at":"2026-08-15T23:38:45.339140Z"},"links":{"citing_paper":"/paper/2505.04284"},"observation_digest":"sha256:fd01558d6353c0ad25c38258b1c3eef0ef1cd2b7264a402e76a2742ac3b0bc5a","observation_id":"890d1e95-adb0-4869-b8dc-2126ea22f7f2","resolution":{"observed_at":"2026-08-15T23:38:46.431517Z","resolver_source":"raw_fallback","status":"unresolved"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-15T23:38:46.411991Z","title":null,"venue":null,"work_id":"4947b013-793b-424f-a929-14c191c0c352","year":2019},"citing_paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance","version":1},"reference_index":22,"source":"pdf_text","source_observed_at":"2026-08-15T23:38:45.343748Z"},"links":{"citing_paper":"/paper/2505.04284"},"observation_digest":"sha256:82b04598e5b7ad4b2a5d30ca9801cd027a34fc556714f3ca7d8fc37f80308213","observation_id":"4a623baf-791e-4099-8ffe-fd9f68488607","resolution":{"observed_at":"2026-08-15T23:38:46.416897Z","resolver_source":"raw_fallback","status":"unresolved"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-15T23:38:46.344894Z","title":"Mohammadi, F","venue":null,"work_id":"6d09f873-ffe0-415f-b69d-3211705a568c","year":2023},"citing_paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance","version":1},"reference_index":23,"source":"pdf_text","source_observed_at":"2026-08-15T23:38:45.404060Z"},"links":{"citing_paper":"/paper/2505.04284"},"observation_digest":"sha256:712142a9dd633f1b7a004a6907bff48938d58a68e40b83e20d4a72ce07b3f6b4","observation_id":"854c4eaf-b7f2-4d48-a8c2-b2ee031e76f3","resolution":{"observed_at":"2026-08-15T23:38:46.373976Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-15T23:38:46.328450Z","title":"Nikfarjam, A","venue":null,"work_id":"23a59c5d-6c36-437a-9d15-b688b64cb01e","year":2015},"citing_paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance","version":1},"reference_index":24,"source":"pdf_text","source_observed_at":"2026-08-15T23:38:45.532928Z"},"links":{"citing_paper":"/paper/2505.04284"},"observation_digest":"sha256:94817560577e793bf6523ac632da586bc06c593a930405c11af0cfa3961eee79","observation_id":"56bd61da-cb4b-4d2e-a6cc-be7cc2ce13c0","resolution":{"observed_at":"2026-08-15T23:38:46.333110Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-15T23:38:46.313234Z","title":"Oronoz, K","venue":null,"work_id":"c60f5f3c-a5c4-483e-9787-f1eaa6f07772","year":2015},"citing_paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance","version":1},"reference_index":25,"source":"pdf_text","source_observed_at":"2026-08-15T23:38:45.603475Z"},"links":{"citing_paper":"/paper/2505.04284"},"observation_digest":"sha256:b43408c27551b2d5ee7c8a70fc98ab991cde70aeac1b07f6f3c654273fee85e2","observation_id":"7906c783-fa1a-45ae-bbb5-5be2d93c2caa","resolution":{"observed_at":"2026-08-15T23:38:46.317891Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-15T23:38:46.297957Z","title":"Papineni, S","venue":null,"work_id":"8c6ade31-7858-4d9b-9e66-858f4bc56ed5","year":2002},"citing_paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance","version":1},"reference_index":26,"source":"pdf_text","source_observed_at":"2026-08-15T23:38:45.608757Z"},"links":{"citing_paper":"/paper/2505.04284"},"observation_digest":"sha256:4ef94e77e80b4c961acb273164076d74248d61da59fa9ed75a14e9cffb23f7b0","observation_id":"cf7e27cc-d86c-4576-b2c0-2db03af248cc","resolution":{"observed_at":"2026-08-15T23:38:46.302872Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-15T23:38:46.281549Z","title":"Patki, A","venue":null,"work_id":"a39fd70b-930f-4826-9a41-8e046feecc41","year":2014},"citing_paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance","version":1},"reference_index":27,"source":"pdf_text","source_observed_at":"2026-08-15T23:38:45.613615Z"},"links":{"citing_paper":"/paper/2505.04284"},"observation_digest":"sha256:41d453a161472afd3d2616a734f6dacd072a5925037ec2c9e457f06141679e1e","observation_id":"0a22e6ac-a3c1-4a62-ab32-a189a4c623fa","resolution":{"observed_at":"2026-08-15T23:38:46.286882Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-15T23:38:46.230303Z","title":"Rafailov, A","venue":null,"work_id":"37f95fab-557f-426d-86d2-279ed6e4e597","year":2024},"citing_paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance","version":1},"reference_index":28,"source":"pdf_text","source_observed_at":"2026-08-15T23:38:45.618340Z"},"links":{"citing_paper":"/paper/2505.04284"},"observation_digest":"sha256:b4918b079ec048e251d98e3c6748af686252bbd384599ae86ed6d89c55926038","observation_id":"40182810-7aab-42e9-ad7a-d6e04875cc70","resolution":{"observed_at":"2026-08-15T23:38:46.252599Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-15T23:38:45.623451Z","title":"Raffel, N","venue":null,"work_id":null,"year":2020},"citing_paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance","version":1},"reference_index":29,"source":"pdf_text","source_observed_at":"2026-08-15T23:38:45.623451Z"},"links":{"citing_paper":"/paper/2505.04284"},"observation_digest":"sha256:1122b41cf6cb1e057cfc4ca06da449f749b5abab202d5fdc4d9cd1c2c1e18b24","observation_id":"be31d5f9-2105-463d-83ad-f4a3a2c379fd","resolution":{"observed_at":"2026-08-15T23:38:45.623451Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"1908.10084","last_updated":"2019-08-27T08:50:17Z","snapshot_observed_at":"2026-08-14T05:02:11.716316Z","submitted_at":"2019-08-27T08:50:17Z","title":"Sentence-BERT: Sentence Embeddings using Siamese BERT-Networks","version":1},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"1908.10084","snapshot_observed_at":"2026-08-15T23:38:45.628369Z","title":null,"venue":null,"work_id":null,"year":1908},"citing_paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance","version":1},"reference_index":30,"source":"pdf_text","source_observed_at":"2026-08-15T23:38:45.628369Z"},"links":{"cited_paper":"/paper/1908.10084","citing_paper":"/paper/2505.04284"},"observation_digest":"sha256:1606dd9e880fe873fc024c5c99c34b69448b65adf98e34cd57a20a81af67fde9","observation_id":"10802c05-c647-4c3e-be3f-2f37815147b0","resolution":{"observed_at":"2026-08-15T23:38:45.628369Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2405.09589","last_updated":"2024-10-03T09:00:35Z","snapshot_observed_at":"2026-08-16T13:52:32.830471Z","submitted_at":"2024-05-15T10:16:25Z","title":"A Comprehensive Survey of Hallucination in Large Language, Image, Video and Audio Foundation Models","version":4},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2405.09589","snapshot_observed_at":"2026-08-15T23:38:45.633747Z","title":"Sahoo, P","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance","version":1},"reference_index":31,"source":"pdf_text","source_observed_at":"2026-08-15T23:38:45.633747Z"},"links":{"cited_paper":"/paper/2405.09589","citing_paper":"/paper/2505.04284"},"observation_digest":"sha256:cd47fb8ad9da58858bbbe27144f2843471b35124be1718f1db845ca5798ebc54","observation_id":"0a070b39-3c22-4770-a0a7-b442bf6cb48f","resolution":{"observed_at":"2026-08-15T23:38:45.633747Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-15T23:38:46.192691Z","title":"Sarker and G","venue":null,"work_id":"8ca3db6c-6ac7-44d3-b55c-1795ed461572","year":2015},"citing_paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance","version":1},"reference_index":33,"source":"pdf_text","source_observed_at":"2026-08-15T23:38:45.644607Z"},"links":{"citing_paper":"/paper/2505.04284"},"observation_digest":"sha256:cb74e6c412b7b990ce7b98201d7723c11ee19047a0f6b494b14f24b0d3e33cfc","observation_id":"bb314785-593a-4b79-be6a-136c3b2ee1a1","resolution":{"observed_at":"2026-08-15T23:38:46.197768Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-15T23:38:46.175793Z","title":null,"venue":null,"work_id":"f2ec7adf-dbcd-4a47-97ee-6059ada0f234","year":2015},"citing_paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance","version":1},"reference_index":34,"source":"pdf_text","source_observed_at":"2026-08-15T23:38:45.649431Z"},"links":{"citing_paper":"/paper/2505.04284"},"observation_digest":"sha256:476f6cc0dab365ef35be8b9b0f9faae89417e9ab885a10afae7d975c43209cf0","observation_id":"5707bc3a-83a3-463b-a7a0-03166755188a","resolution":{"observed_at":"2026-08-15T23:38:46.180633Z","resolver_source":"raw_fallback","status":"unresolved"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-15T23:38:46.159336Z","title":"Adversedrugre- actionsatadversedrugreactionmonitoringcenterinraipur:Analysisofspontaneousreports during 1 year.Indian journal of pharmacology, 49(6):432–437, 2017","venue":null,"work_id":"1cf73519-4a98-4151-89c6-8f67d354d4ed","year":2017},"citing_paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance","version":1},"reference_index":35,"source":"pdf_text","source_observed_at":"2026-08-15T23:38:45.653965Z"},"links":{"citing_paper":"/paper/2505.04284"},"observation_digest":"sha256:373c2af97fc6983d32de55280ababd8c39fa2816305b1b0146e1f90e84ffafaa","observation_id":"bde63956-a3da-4a2d-bc11-d4f531592dd8","resolution":{"observed_at":"2026-08-15T23:38:46.164924Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-15T23:38:46.133348Z","title":null,"venue":null,"work_id":"9f4d75ae-f24e-4d58-8766-6304418c7856","year":2024},"citing_paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance","version":1},"reference_index":36,"source":"pdf_text","source_observed_at":"2026-08-15T23:38:45.752650Z"},"links":{"citing_paper":"/paper/2505.04284"},"observation_digest":"sha256:fb85cf1d44d51a32ac94bba90b566eb3036a99182f21c61bd2a735a946d58bb0","observation_id":"c0658744-04cf-4a7c-9749-156f9b0650a9","resolution":{"observed_at":"2026-08-15T23:38:46.147475Z","resolver_source":"raw_fallback","status":"parse_uncertain"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-15T23:38:46.056208Z","title":"Tunstall, E","venue":null,"work_id":"9eaa4e6d-9a2f-455f-aacc-0408a53a2293","year":2023},"citing_paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance","version":1},"reference_index":37,"source":"pdf_text","source_observed_at":"2026-08-15T23:38:45.845833Z"},"links":{"citing_paper":"/paper/2505.04284"},"observation_digest":"sha256:64d6f285605ebed1ce48d6fe385c013a3a56c5a7cb573d5efe719f631ff132ff","observation_id":"ef9eafe4-a04e-45b3-b5fd-6284195ff1c7","resolution":{"observed_at":"2026-08-15T23:38:46.083395Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-15T23:38:46.030852Z","title":null,"venue":null,"work_id":"4567baa5-875b-42f6-a85e-3d246b593e68","year":2005},"citing_paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance","version":1},"reference_index":38,"source":"pdf_text","source_observed_at":"2026-08-15T23:38:45.886872Z"},"links":{"citing_paper":"/paper/2505.04284"},"observation_digest":"sha256:a73462a4b1ef376a367927daca4d28ed975875d7c3a9d8f09ef243443ba209ad","observation_id":"3a3d3f7e-3338-496e-b82a-b5b4a5cdd3f7","resolution":{"observed_at":"2026-08-15T23:38:46.037876Z","resolver_source":"raw_fallback","status":"unresolved"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"1904.09675","last_updated":"2020-02-24T18:59:28Z","snapshot_observed_at":"2026-07-29T15:42:51.774083Z","submitted_at":"2019-04-21T23:08:53Z","title":"BERTScore: Evaluating Text Generation with BERT","version":3},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"1904.09675","snapshot_observed_at":"2026-08-15T23:38:45.918576Z","title":"Zhang, V","venue":null,"work_id":null,"year":1904},"citing_paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance","version":1},"reference_index":39,"source":"pdf_text","source_observed_at":"2026-08-15T23:38:45.918576Z"},"links":{"cited_paper":"/paper/1904.09675","citing_paper":"/paper/2505.04284"},"observation_digest":"sha256:ff374272c2250828252bf87abfe8d7cc0b80ee37308d2425ff15cb3e1706779a","observation_id":"851e3673-8f38-4cc1-9b11-e876d624c402","resolution":{"observed_at":"2026-08-15T23:38:45.918576Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}}],"paper":{"arxiv_id":"2505.04284","last_updated":"2025-05-07T09:40:18Z","latest_version":1,"primary_category":"cs.CL","snapshot_observed_at":"2026-08-18T08:21:25.723097Z","submitted_at":"2025-05-07T09:40:18Z","title":"GASCADE: Grouped Summarization of Adverse Drug Event for Enhanced Cancer Pharmacovigilance"},"reference_resolution":{"displayed":38,"state_counts":{"malformed_identifier":0,"metadata_mismatch":0,"parse_uncertain":1,"unresolved":17,"verified_exact":0,"verified_fuzzy":20},"total_outbound_references":38},"refusal":"A citation records a reference. It does not transfer a finding from one paper to another.","schema":"pith.paper-citation-record.v1","standing_sources":[{"observed_at":"2026-08-19T06:32:44.657259+00:00","source":"crossref"},{"observed_at":"2026-08-19T06:32:39.956319+00:00","source":"retraction_watch"}],"thesis":"As of 19 August 2026, this Paper Citation Record lists 38 of 38 outbound references and 0 inbound Pith citation observations for arXiv:2505.04284."}